Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Handelsinvest Investeringsforvaltning

Handelsinvest Investeringsforvaltning reduced its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 34.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,515 shares of the biotechnology company’s stock after selling 787 shares during the period. Handelsinvest Investeringsforvaltning’s holdings in Axon Enterprise were worth $474,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in AXON. LPL Financial LLC raised its holdings in shares of Axon Enterprise by 6.6% during the third quarter. LPL Financial LLC now owns 43,559 shares of the biotechnology company’s stock worth $8,668,000 after purchasing an additional 2,715 shares during the last quarter. Mariner LLC raised its holdings in shares of Axon Enterprise by 22.3% during the third quarter. Mariner LLC now owns 7,487 shares of the biotechnology company’s stock worth $1,490,000 after purchasing an additional 1,367 shares during the last quarter. Stifel Financial Corp raised its holdings in shares of Axon Enterprise by 2.4% during the third quarter. Stifel Financial Corp now owns 21,961 shares of the biotechnology company’s stock worth $4,370,000 after purchasing an additional 506 shares during the last quarter. Bank of Nova Scotia increased its holdings in Axon Enterprise by 210.8% in the third quarter. Bank of Nova Scotia now owns 11,352 shares of the biotechnology company’s stock valued at $2,259,000 after buying an additional 7,700 shares in the last quarter. Finally, Advisors Asset Management Inc. increased its holdings in Axon Enterprise by 18.9% in the third quarter. Advisors Asset Management Inc. now owns 18,650 shares of the biotechnology company’s stock valued at $3,711,000 after buying an additional 2,965 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Julie A. Cullivan sold 478 shares of the business’s stock in a transaction that occurred on Tuesday, May 28th. The shares were sold at an average price of $286.04, for a total value of $136,727.12. Following the sale, the director now directly owns 5,546 shares of the company’s stock, valued at approximately $1,586,377.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, Director Julie A. Cullivan sold 993 shares of the company’s stock in a transaction that occurred on Friday, May 31st. The shares were sold at an average price of $281.72, for a total transaction of $279,747.96. Following the sale, the director now directly owns 4,553 shares of the company’s stock, valued at approximately $1,282,671.16. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Julie A. Cullivan sold 478 shares of the company’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $286.04, for a total transaction of $136,727.12. Following the sale, the director now directly owns 5,546 shares in the company, valued at $1,586,377.84. The disclosure for this sale can be found here. In the last three months, insiders have sold 89,447 shares of company stock valued at $27,684,677. Company insiders own 5.70% of the company’s stock.

Axon Enterprise Trading Up 0.8 %

NASDAQ:AXON traded up $2.39 on Wednesday, hitting $295.57. The stock had a trading volume of 9,857 shares, compared to its average volume of 490,701. The company has a quick ratio of 2.55, a current ratio of 2.91 and a debt-to-equity ratio of 0.37. The stock has a market cap of $22.31 billion, a price-to-earnings ratio of 85.73 and a beta of 0.95. The company has a fifty day moving average price of $294.99 and a two-hundred day moving average price of $285.77. Axon Enterprise, Inc. has a 1-year low of $175.37 and a 1-year high of $329.87.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.20. The company had revenue of $460.74 million for the quarter, compared to analyst estimates of $441.57 million. Axon Enterprise had a net margin of 15.60% and a return on equity of 11.71%. Axon Enterprise’s revenue was up 34.3% on a year-over-year basis. During the same period in the previous year, the business posted $0.51 EPS. Equities research analysts expect that Axon Enterprise, Inc. will post 2.35 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on AXON. JMP Securities reaffirmed a “market outperform” rating and issued a $375.00 price objective on shares of Axon Enterprise in a report on Tuesday, May 7th. Morgan Stanley lifted their price objective on shares of Axon Enterprise from $285.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, April 26th. StockNews.com lowered shares of Axon Enterprise from a “buy” rating to a “hold” rating in a research report on Thursday, March 14th. Craig Hallum lifted their target price on shares of Axon Enterprise from $325.00 to $370.00 and gave the company a “buy” rating in a research report on Tuesday, May 7th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a research report on Thursday, April 11th. Two research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $335.27.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.